n-3 Polyunsaturated fatty acids modulate carcinogen-directed non-coding microRNA signatures in rat colon

Carcinogenesis

Volumn 30, Issue 12, 2009, Pages 2077-2084

  Davidson, Laurie A ^a   Wang, Naisyin ^a   Shah, Manasvi S ^a   Lupton, Joanne R ^a   Ivanov, Ivan ^a,b   Chapkin, Robert S ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; MICRORNA; OMEGA 3 FATTY ACID; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; CARCINOGEN; FISH OIL; PECTIN; UNSATURATED FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER STAGING; CHEMICAL CARCINOGENESIS; COLON ADENOCARCINOMA; DIET THERAPY; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; ADENOCARCINOMA; ANIMAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; COLON; COLON TUMOR; GENE EXPRESSION PROFILING; GENETIC EPIGENESIS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ANIMALS; AZOXYMETHANE; CARCINOGENS; COLON; COLONIC NEOPLASMS; EPIGENESIS, GENETIC; FATTY ACIDS, UNSATURATED; FISH OILS; GENE EXPRESSION PROFILING; MALE; MICRORNAS; PECTINS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 73949158230     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp245     Document Type: Article

References (68)

1. Esquela-Kerscher, A. et al. (2006) Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259-269.
2. Sood, P. et al. (2006) Cell-type-specific signatures of microRNAs on target mRNA expression. Proc. Natl Acad. Sci. USA, 103, 2746-2751.
3. Michael, M.Z. et al. (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res., 1, 882-891.
4. Akao, Y. et al. (2006) let-7 microRNA as a potential growth suppressor in human colon cancer cells. Biol. Pharm. Bull., 29, 903-906.
5. Bandres, E. et al. (2006) Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol. Cancer, 5, 29.
6. Monzo, M. et al. (2008) Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res., 18, 823-833.
7. Schepeler, T. et al. (2008) Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res., 68, 6416-6424.
8. Cummins, J.M. et al. (2006) The colorectal microRNAome. Proc. Natl Acad. Sci. USA, 103, 3687-3692.
9. Cheng, A.M. et al. (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res., 33, 1290-1297.
10. Carthew, R.W. (2006) Gene regulation by microRNAs. Curr. Opin. Genet. Dev., 16, 203-208.
11. Grady, W.M. et al. (2008) Epigenetic silencing of the intronic microRNA has-miR-342 and its host gene EVL in colorectal cancer. Oncogene, 27, 3880-3888.
12. Lu, J. et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, 834-838.
13. Krutzfeldt, J. et al. (2006) Strategies to determine the biological function of microRNAs. Nat. Genet., 38 (suppl), S14-S19.
14. Jemal, A. et al. (2008) Cancer Statistics, 2008. CA Cancer J. Clin., 58, 71-96.
15. Reddy, B.S. et al. (1991) Effect of diets high in ω-3 and ω-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res., 51, 487-491.
16. Anti, M. et al. (1992) Effect of ω-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer. Gastroenterology, 103, 883-891.
17. Anti, M. et al. (1994) Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas. Gastroenterology, 107, 1709-1718.
18. Caygill, C.P. et al. (1996) Fat, fish, fish oil and cancer. Br. J. Cancer, 74, 159-164.
19. Chang, W.C. et al. (1998) Fish oil blocks azoxymethane-induced tumorigenesis by increased cell differentiation and apoptosis rather than decreased cell proliferation. J. Nutr., 18, 351-357.
20. Cheng, J. et al. (2003) Increased intake of n-3 polyunsaturated fatty acids elevates the level of apoptosis in the normal sigmoid colon of patients polypectomized for adenomas/tumors. Cancer Lett., 193, 17-24.
21. Davidson, L.A. et al. (2004) Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat. Cancer Res., 64, 6797-6804.
22. Hall, M.N. et al. (2007) Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer. Cancer Epidemiol. Biomarkers Prev., 16, 314-321.
23. Pot, G.K. et al. (2008) Opposing associations of serum n-3 and n-6 polyunsaturated fatty acids with colorectal adenoma risk: an endoscopy-based case-control study. Int. J. Cancer, 123, 1974-1977.
24. Hall, M.N. et al. (2008) A 22-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men. Cancer Epidemiol. Biomarkers Prev., 17, 1136-1143.
25. Whelan, J. et al. (2004) Dietary (n-6) PUFA and intestinal tumorigenesis. J. Nutr., 134, 3421S-3426S.
26. Chang, W.C. et al. (1997) Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis. Carcinogenesis, 18, 721-730.
27. Sanders, L.M. et al. (2004) An increase in reactive oxygen species by dietary fish oil coupled with the attenuation of antioxidant defenses by dietary pectin enhances rat colonocyte apoptosis. J. Nutr., 134, 3233-3238.
28. Crim, K.C. et al. (2008) Upregulation of p21waf1/cip1 expression in vivo by butyrate administration can be chemoprotective or chemopromotive depending on the lipid component of the diet. Carcinogenesis, 29, 1415-1420.
29. Ahnen, D.J. (1985) Are animal models of colon cancer relevant to human disease. Digest. Dis. Sci., 30, 103S-106S.
30. Reddy, B.S. (1994) Chemoprevention of colon cancer by dietary fatty acids. Cancer Metas. Rev., 13, 285-302.
31. Xiao, F. et al. (2009) miRecords: an integrated resource for microRNAtarget interactions. Nucleic Acids Res., 37, D105-D110.
32. Bolstad, B.M. et al. (2003) A comparison of normalization methods for high density oligonucleotide array data based on bias and variance. Bioinformatics, 19, 185-193.
33. Benjamini, Y. et al. (1995) Controlling the false discovery rate-a practical and powerful approach to multiple testing. J.R. Stat. Soc. B, 57, 289-300.
34. Breiman, L. (2001) Random forests. Mach. Learn., 45, 5-32.
35. Cheng, C. et al. (2008) Inferring microRNA activities by combining gene expression with microRNA target prediction. PLOS One, 3, e1989.
36. Cimmino, A. et al. (2005) MiR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl Acad. Sci. USA, 102, 13944-13949.
37. Xia, L. et al. (2008) mirR-15b and mir16 modulate multidrug resistance by targeting bcl2 in human gastric cancer cells. Int. J. Cancer, 123, 372-379.
38. Xia, H. et al. (2009) MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells. Biochem. Biophys. Res. Commun., 380, 205-210.
39. Beitzinger, M. et al. (2007) Identification of human microRNA targets from isolated argonaute protein complexes. RNA Biol., 4, 76-84.
40. Wang, W.X. et al. (2008) The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci., 28, 1213-1223.
41. Koensgen, D. et al. (2007) Expression analysis and RNA localization of PAI-RBP (SERBP1) in epithelial ovarian cancer: association with tumor progression. Gynecol. Oncol., 107, 266-273.
42. Xia, L. et al. (2008) miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int. J. Cancer, 123, 372-379.
43. Asangani, I.A. et al. (2008) MicroRNA -21 (miR-21) post-transcriptionally down regulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 27, 2128-2136.
44. Vasudevan, S. et al. (2007) Switching from repression to activation: micro-RNAs can up-regulate translation. Science, 318, 1931-1934.
45. Tavani, A. et al. (2003) n-3 polyunsaturated fatty acid intake and cancer risk in Italy and Switzerland. Int. J. Cancer, 105, 113-116.
46. Chapkin, R.S. et al. (2007) Colon cancer, fatty acids and anti-inflammatory compounds. Curr. Opin. Gastroenterol., 23, 48-54.
47. Ma, D.W. et al. (2004) n-3 PUFA alter caveolae lipid composition and resident protein localization in mouse colon. FASEB J., 18, 1040-1042.
48. Seo, J. et al. (2006) Docosahexaenoic acid selectively inhibits plasma membrane targeting of lipidated proteins. FASEB J., 20, 770-772.
49. Hong, M.Y. et al. (2000) Dietary fish oil reduces DNA adduct levels in rat colon in part by increasing apoptosis during tumor initiation. Cancer Epidemiol. Biomarkers Prev., 9, 819-826.
50. Hong, M.Y. et al. (2002) Fish oil increases mitochondrial phospholipid unsaturation, upregulating reactive oxygen species and apoptosis in rat colonocytes. Carcinogenesis, 23, 1919-1925.
51. 2+ accumulation. Cancer Res., 67, 5561-5568.
52. 2+ accumulation in human colon cancer cells and primary cultures of rat colonic crypts. Am. J. Physiol. Gastrointest. Liver Physiol., 293, G935-G943.
53. Tomaru, Y. et al. (2006) Cancer research with non-coding RNA. Cancer Sci., 97, 1285-1290.
54. Schetter, A.J. et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA, 299, 425-436.
55. Gaur, A. et al. (2007) Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res., 67, 2456-2468.
56. O'Hara, S.P. et al. (2009) MicroRNAs: key modulators of posttranscriptional gene expression. Gastroenterology, 136, 17-25.
57. Raver-Shapira, N. et al. (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell, 26, 1-13.
58. Tazawa, H. et al. (2007) Tumor-suppressive miR-34a induces senescencelike growth arrest through modulation of E2F pathway in human colon cancer cells. Proc. Natl Acad. Sci. USA, 104, 15472-15477.
59. Wang, Y. et al. (2008) Profiling microRNA expression in hapatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J. Biol. Chem., 283, 13205-13215.
60. Fazi, F. et al. (2007) Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell, 12, 457-466.
61. Cheng, H.M. et al. (2007) miroRNA modulation of circadian clock period and entrainment. Neuron, 54, 813-829.
62. Braun, C.J. et al. (2008) p53-responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest. Cancer Res., 68, 10094-10104.
63. Georges, S.A. et al. (2008) Coordinated regulation of cell cycle transcripts by p53-inducible microRNAs, miR-192 and miR-215. Cancer Res., 68, 10105-10112.
64. Song, B. et al. (2008) miR-192 regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clin. Cancer Res., 14, 8080-8086.
65. Hino, K. et al. (2008) Inducible expression of microRNA-194 is regulated by HNF-1α during intestinal epithelial cell differentiation. RNA, 14, 1433-1442.
66. Ladeiro, Y. et al. (2008) MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology, 47, 1955-1963.
67. Scott, G.K. et al. (2006) Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res., 66, 1277-1281.
68. Davis, C.D. et al. (2008) Evidence for dietary regulation of microRNA expression in cancer cells. Nutr. Rev., 66, 477 482.